✦ LIBER ✦

The B-cell response to a primary and booster course of MenACWY-CRM197 vaccine administered at 2, 4 and 12 months of age

✍ Scribed by Blanchard-Rohner, Geraldine; Snape, Matthew D.; Kelly, Dominic F.; O’Connor, Daniel; John, Tessa; Clutterbuck, Elizabeth A.; Ohene-Kena, Brigitte; Klinger, Chaam L.; Odrljin, Tatjana; Pollard, Andrew J.

Book ID: 120824462
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 777 KB
Volume: 31
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2013.03.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Responses to primary and a booster dose

Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age

✍ Li-Min Huang; Chin-Yun Lee; Tzou-Yien Lin; Jong-Min Chen; Ping-Ing Lee; Ching-Yi 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 847 KB

Immune response to a combined hepatitis

Immune response to a combined hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine administered to infants at 2, 4 and 6 months of age

✍ Javier Aristegui; Elisa Garrote; Antonio González; Juan-Pedro Arrate; Alberto Pe 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 509 KB

Comparison of the immunogenicity and rea

Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age

✍ I. Tichmann; H. Preidel; D. Grunert; S. Habash; R. Schult; R. Maier; P.K. Gildbe 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Safety and immunogenicity of a recombina

Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age

✍ David P. Greenberg; Constance M. Vadheim; S. Michael Marcy; Susan Partridge; Jen 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 825 KB

Dose-response to acellular pertussis vac

Dose-response to acellular pertussis vaccine and comparison with whole cell pertussis vaccine at 15–24 months and 4–6 years of age

✍ Barry S. Auerbach; Modena E. Wilson; Alan M. Lake; Adamadia Deforest; Mark Stein 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 702 KB

Large scale safety study of a liquid hex

Large scale safety study of a liquid hexavalent vaccine (D-T-acP–IPV–PRP∼T–HBs) administered at 2, 4, 6 and 12–14 months of age

✍ J.G. Liese; S. Stojanov; F. Berut; P. Minini; E. Harzer; S. Jow; F. Schödel; J. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 64 KB